HaemTRIAL

Have you ever wondered about the long-term risk of recurrence in patients with isolated SSPE? New data suggest the risk may not exceed the threshold for extended duration anticoagulation. Case by case decision is needed. 👉sciencedirect.com/science/articl… @ThrombosisCan @canvector @JRand083 @ThrombosisRese1 @OttMethodsCentr #VTE #PulmonaryEmbolism #MedTwitter

Prof. @isabellemahe1 presents API-CAT at #ACC2025, published in @NEJM Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in patients with cancer. nejm.org/doi/full/10.10…

Very pleased to be involved with this project that is the first step on the ladder to interventional studies that can improve the experience of women who develop VTE and need anticoagulation. DON'T STOP COC IN WOMEN WITH ACUTE VTE ON ANTICOAGULATION!

So right. Whilst AI is inevitable in healthcare…we first need to get the basics right. Computers that work and primary and secondary care databases that talk to each other are necessary bedrocks.

We don't need to debate whether it's better to be a generalist or a specialist. The world needs both. Specialists excel at zooming in. They see the details to deepen our knowledge. Generalists excel at zooming out. They see around corners to broaden our view.

@bmj_latest So much evidence behind such a simple and safe intervention. Thank you for writing this Ian Roberts and @CHToh1. All haematologists should be advocates of TxA with surgical colleagues. Saddened that even with such great evidence, influencing change can be so slow.

Tranexamic acid safely reduces surgical bleeding and the need for blood transfusion. Greater use of tranexamic acid in surgery is important, especially in low and middle income settings where blood stocks are lower and risks higher, says Analysis bmj.com/content/385/bm…

@HaemSTAR_UK @PipNicolson @richardbuka

To help and express your interest in taking part– please give us 15 min of your time to fill out this simple 3-part survey. redcap.link/secondarypolyc…

Are you a clinician who sees patients with secondary polycythaemia? Are you frustrated by the lack of an evidence base for treating these patients? Does your practise differ from your colleagues when treating these patients?

Article published in @RPTHjournal challenges the hypothesis that long covid is due to microclots. tinyurl.com/2yy9crb6 #longcovid #covid19

thelancet.com/journals/laneu… Yassi et al. Lancet Neurology 2024. Behind a paywall and I can't see how the study was powered. Headline results: Tranexamic Acid doesn't prevent haematoma expansion / improve functional status or mortality after ICH. But very small study with v wide CIs.

@Ed_Pinches @unibirmingham @traceychan_1 Very good prospects for the future @traceychan_1!

A new blood test is being developed @unibirmingham to help diagnose a form of incurable blood cancer, myeloma. @traceychan_1 says these could be relatively low cost and may also be done at a patient's local GP surgery. bloodcancer.org.uk/news/new-blood…

@Ed_Pinches @AidanHaslam valuable work @AidanHaslam. Congratulations on getting the funding!

@AidanHaslam £320k new project to identify who with MGUS are at the highest risk of developing myeloma, is also featured.

Very exciting discussions with potential industry partners today. So encouraged.

Getting excited about seeing @HaemSTAR_UK #RAPIDO data at #BSH2024…2 hours to go

@PipNicolson is having some exciting conversations with a clinical trials unit this week about finding a physical home for @HaemTRIAL